Market By Application, Component, And Geography | Forecast 2021-2028
Triton Market Research’s detailed analysis of the global precision medicine market depicts that, based on revenue, the market is estimated to advance at a CAGR of 9.79% over the forecasting years 2021-2028. In 2020, the market garnered revenue worth $62.60 billion, and is evaluated to attain $128.17 billion by 2028.
Precision medicine includes a detailed study of patient-specific information to diagnose and characterize diseases. It holds immense potential to restructure the healthcare industry. For instance, precision medicine is primarily used for cancer treatment, including breast cancer. The promising technologies have attracted several biopharmaceutical companies and technology giants, such as Microsoft, to invest in the market.
The multi-faceted approach to patient care in precision medicine allows healthcare providers to avoid adverse drug reactions, improve administration methods, focus efforts on prevention and early intervention, increase treatment options, and improve the quality of life. The rising prevalence of chronic diseases, especially in the elderly population, is a major factor contributing to the growth of the studied market. In recent years, the occurrence of chronic diseases has been increasing irrespective of the region. This increase in diseases is expected to follow the same trends in the near future.
The study aims to get an overview of the global precision medicine market in terms of various factors. Within this report, the key insight and the market summary regarding the market have been discussed. Also, the impact of COVID-19, supply chain outlook, regulatory policies & framework, the etymology of precision medicine, market attractiveness matrix, vendor scorecard, and key market strategies have been studied in detail.
Furthermore, the digital collaboration among research groups and organizations, along with the identification of genetic makeup in the human genome, are other factors driving the global market’s growth. The considered market can leverage key opportunities like investments by government and private players in cancer treatment, and demand for preventive care to reach its projected growth.
However, the industry is facing market restraints, such as stringent drug approval processes, security risks pertaining to data sharing, and changes in reimbursement and regulatory process, obstructing the precision medicine market’s progress.
Major geographies covered in the precision medicine market by region are:
• North America: Canada and United States
• Europe: Russia, Spain, United Kingdom, Germany, France, Italy, and Rest of Europe
• Asia-Pacific: Australia & New Zealand, Japan, India, ASEAN countries, South Korea, China, and Rest of Asia-Pacific
• Latin America: Mexico, Brazil, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa
The precision medicine market segmentation includes:
• Market by Application:
o Oncology
o Infectious Diseases
o Neurology/Physiatry
o Cardiovascular
o Lifestyle and Endocrinology
o Gastroenterology
o Other Applications
• Market by Component:
o Applied Science
• Genomics
o PCR
o PM NGS
o Genome Editing
o Other Genomics Technologies
• Pharmacogenomics
• Other Applied Sciences
o Precision Therapeutics
• Clinical Trials
• Cell Therapy
• Drug Discovery and Research
• Gene Therapy
o Precision Diagnostics
• Molecular Diagnostics
o Non-Invasive Prenatal Testing (NIPT)
o Companion Diagnostics
o Liquid Biopsy
o Other Molecular Diagnostics
• Medical Imaging
o Imaging Analytics
o Imaging Computer-Aided Detection (CADX)
o Digital Health and Information Technology
• Clinical Decision Support Systems (CDSS)
• Big Data Analytics
• IT Infrastructure
• Genomics Informatics
• In-Silico Informatics
• Mobile Health
The prominent companies profiled in the precision medicine market include Bio-Rad Laboratories Inc, Eagle Genomics Ltd, AstraZeneca Plc, Intomics, Laboratory Corporation of America Holdings, Pfizer Inc, Quest Diagnostics Incorporated, Danaher Corporation, Novartis AG, F Hoffmann-La Roche AG, Biocrates Life Sciences AG, Eli Lilly & Company, Qiagen NV, Abbott Laboratories, and Nanostring Technologies.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT
1. GLOBAL PRECISION MEDICINE MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. KEY INSIGHTS
2.1.1. PRESENCE OF BIOPHARMACEUTICAL COMPANIES
2.1.2. INVESTMENTS IN GENE THERAPY
2.2. IMPACT OF COVID-19 ON PRECISION MEDICINE MARKET
2.3. SUPPLY CHAIN OUTLOOK
2.4. REGULATORY POLICIES & FRAMEWORK
2.5. ETYMOLOGY OF PRECISION MEDICINE
2.6. PORTER’S FIVE FORCES MODEL
2.7. MARKET ATTRACTIVENESS INDEX
2.8. VENDOR LANDSCAPE
2.9. KEY MARKET STRATEGIES
2.9.1. CONTRACTS AND PARTNERSHIPS
2.9.2. BUSINESS EXPANSION & DIVESTITURES
2.9.3. ACQUISITIONS & MERGERS
2.9.4. NEW PRODUCT LAUNCHES
2.10. MARKET DRIVERS
2.10.1. HIGH PREVALENCE OF CHRONIC DISEASES IN THE AGING POPULATION
2.10.2. DIGITAL COLLABORATION AMONG RESEARCH GROUPS AND ORGANIZATIONS
2.10.3. IDENTIFICATION OF GENETIC MAKEUP IN THE HUMAN GENOME
2.11. MARKET CHALLENGES
2.11.1. STRINGENT DRUG APPROVAL PROCESS
2.11.2. SECURITY THREATS PERTAINING TO DATA SHARING
2.11.3. CHANGES IN REIMBURSEMENT AND REGULATORY PROCESS
2.12. MARKET OPPORTUNITIES
2.12.1. INVESTMENTS BY GOVERNMENT AND PRIVATE PLAYERS IN CANCER TREATMENT
2.12.2. DEMAND FOR PREVENTIVE CARE
3. GLOBAL PRECISION MEDICINE MARKET - BY APPLICATION
3.1. ONCOLOGY
3.2. INFECTIOUS DISEASES
3.3. NEUROLOGY/PHYSIATRY
3.4. CARDIOVASCULAR
3.5. LIFESTYLE AND ENDOCRINOLOGY
3.6. GASTROENTEROLOGY
3.7. OTHER APPLICATIONS
4. GLOBAL PRECISION MEDICINE MARKET - BY COMPONENT
4.1. APPLIED SCIENCE
4.1.1. GENOMICS
4.1.1.1. PCR
4.1.1.2. PM NGS
4.1.1.3. GENOME EDITING
4.1.1.4. OTHER GENOMICS TECHNOLOGIES
4.1.2. PHARMACOGENOMICS
4.1.3. OTHER APPLIED SCIENCES
4.2. PRECISION THERAPEUTICS
4.2.1. CLINICAL TRIALS
4.2.2. CELL THERAPY
4.2.3. DRUG DISCOVERY AND RESEARCH
4.2.4. GENE THERAPY
4.3. PRECISION DIAGNOSTICS
4.3.1. MOLECULAR DIAGNOSTICS
4.3.1.1. NON-INVASIVE PRENATAL TESTING (NIPT)
4.3.1.2. COMPANION DIAGNOSTICS
4.3.1.3. LIQUID BIOPSY
4.3.1.4. OTHER MOLECULAR DIAGNOSTICS
4.3.2. MEDICAL IMAGING
4.3.2.1. IMAGING ANALYTICS
4.3.2.2. IMAGING COMPUTER-AIDED DETECTION (CADX)
4.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY
4.4.1. CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
4.4.2. BIG DATA ANALYTICS
4.4.3. IT INFRASTRUCTURE
4.4.4. GENOMICS INFORMATICS
4.4.5. IN-SILICO INFORMATICS
4.4.6. MOBILE HEALTH
5. GLOBAL PRECISION MEDICINE MARKET – REGIONAL OUTLOOK
5.1. NORTH AMERICA
5.1.1. MARKET BY APPLICATION
5.1.2. MARKET BY COMPONENT
5.1.2.1. APPLIED SCIENCE MARKET BY TYPE
5.1.2.1.1. GENOMICS MARKET BY TYPE
5.1.2.2. PRECISION THERAPEUTICS MARKET BY TYPE
5.1.2.3. PRECISION DIAGNOSTICS MARKET BY TYPE
5.1.2.3.1. MOLECULAR DIAGNOSTICS MARKET BY TYPE
5.1.2.3.2. MEDICAL IMAGING MARKET BY TYPE
5.1.2.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET BY TYPE
5.1.3.  COUNTRY ANALYSIS
5.1.3.1. UNITED STATES
5.1.3.2. CANADA
5.2. EUROPE
5.2.1.  MARKET BY APPLICATION
5.2.2.  MARKET BY COMPONENT
5.2.2.1. APPLIED SCIENCE MARKET BY TYPE
5.2.2.1.1. GENOMICS MARKET BY TYPE
5.2.2.2. PRECISION THERAPEUTICS MARKET BY TYPE
5.2.2.3. PRECISION DIAGNOSTICS MARKET BY TYPE
5.2.2.3.1. MOLECULAR DIAGNOSTICS MARKET BY TYPE
5.2.2.3.2. MEDICAL IMAGING MARKET BY TYPE
5.2.2.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET BY TYPE
5.2.3.  COUNTRY ANALYSIS
5.2.3.1. GERMANY
5.2.3.2. FRANCE
5.2.3.3. UNITED KINGDOM
5.2.3.4. ITALY
5.2.3.5. RUSSIA
5.2.3.6. SPAIN
5.2.3.7. REST OF EUROPE
5.3. ASIA-PACIFIC
5.3.1. MARKET BY APPLICATION
5.3.2. MARKET BY COMPONENT
5.3.2.1. APPLIED SCIENCE MARKET BY TYPE
5.3.2.1.1. GENOMICS MARKET BY TYPE
5.3.2.2. PRECISION THERAPEUTICS MARKET BY TYPE
5.3.2.3. PRECISION DIAGNOSTICS MARKET BY TYPE
5.3.2.3.1. MOLECULAR DIAGNOSTICS MARKET BY TYPE
5.3.2.3.2. MEDICAL IMAGING MARKET BY TYPE
5.3.2.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET BY TYPE
5.3.3. COUNTRY ANALYSIS
5.3.3.1. CHINA
5.3.3.2. JAPAN
5.3.3.3. AUSTRALIA & NEW ZEALAND
5.3.3.4. INDIA
5.3.3.5. SOUTH KOREA
5.3.3.6. ASEAN COUNTRIES
5.3.3.7. REST OF ASIA-PACIFIC
5.4. LATIN AMERICA
5.4.1. MARKET BY APPLICATION
5.4.2. MARKET BY COMPONENT
5.4.2.1. APPLIED SCIENCE MARKET BY TYPE
5.4.2.1.1. GENOMICS MARKET BY TYPE
5.4.2.2. PRECISION THERAPEUTICS MARKET BY TYPE
5.4.2.3. PRECISION DIAGNOSTICS MARKET BY TYPE
5.4.2.3.1. MOLECULAR DIAGNOSTICS MARKET BY TYPE
5.4.2.3.2. MEDICAL IMAGING MARKET BY TYPE
5.4.2.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET BY TYPE
5.4.3. COUNTRY ANALYSIS
5.4.3.1. MEXICO
5.4.3.2. BRAZIL
5.4.3.3. REST OF LATIN AMERICA
5.5. MIDDLE EAST AND AFRICA
5.5.1. MARKET BY APPLICATION
5.5.2. MARKET BY COMPONENT
5.5.2.1. APPLIED SCIENCE MARKET BY TYPE
5.5.2.1.1. GENOMICS MARKET BY TYPE
5.5.2.2. PRECISION THERAPEUTICS MARKET BY TYPE
5.5.2.3. PRECISION DIAGNOSTICS MARKET BY TYPE
5.5.2.3.1. MOLECULAR DIAGNOSTICS MARKET BY TYPE
5.5.2.3.2. MEDICAL IMAGING MARKET BY TYPE
5.5.2.4. DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET BY TYPE
5.5.3.  COUNTRY ANALYSIS
5.5.3.1. SAUDI ARABIA
5.5.3.2. UNITED ARAB EMIRATES
5.5.3.3. TURKEY
5.5.3.4. SOUTH AFRICA
5.5.3.5. REST OF MIDDLE EAST & AFRICA
6. COMPETITIVE LANDSCAPE
6.1. ABBOTT LABORATORIES
6.2. ASTRAZENECA PLC
6.3. BIOCRATES LIFE SCIENCES AG
6.4. BIO-RAD LABORATORIES INC
6.5. DANAHER CORPORATION
6.6. EAGLE GENOMICS LTD
6.7. ELI LILLY & COMPANY
6.8. F HOFFMANN-LA ROCHE AG
6.9. INTOMICS
6.10. LABORATORY CORPORATION OF AMERICA HOLDINGS
6.11. NANOSTRING TECHNOLOGIES
6.12. NOVARTIS AG
6.13. PFIZER INC
6.14. QIAGEN NV
6.15. QUEST DIAGNOSTICS INCORPORATED
7. RESEARCH METHODOLOGY & SCOPE
7.1. RESEARCH SCOPE & DELIVERABLES
7.1.1. OBJECTIVES OF STUDY
7.1.2. SCOPE OF STUDY
7.2. SOURCES OF DATA
7.2.1. PRIMARY DATA SOURCES
7.2.2. SECONDARY DATA SOURCES
7.3. RESEARCH METHODOLOGY
7.3.1. EVALUATION OF PROPOSED MARKET
7.3.2. IDENTIFICATION OF DATA SOURCES
7.3.3. ASSESSMENT OF MARKET DETERMINANTS
7.3.4. DATA COLLECTION
7.3.5. DATA VALIDATION & ANALYSIS
TABLE 1:Â Â Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2:Â Â Â Â Â Â MARKET ATTRACTIVENESS INDEX
TABLE 3:Â Â Â Â Â Â VENDOR LANDSCAPE
TABLE 4:Â Â Â Â Â Â LIST OF CONTRACTS & PARTNERSHIPS
TABLE 5:Â Â Â Â Â Â LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE 6:Â Â Â Â Â Â LIST OF ACQUISITIONS & MERGERS
TABLE 7:Â Â Â Â Â Â LIST OF NEW PRODUCT LAUNCHES
TABLE 8:Â Â Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 9:Â Â Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 10:Â Â Â Â GLOBAL APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11:Â Â Â Â GLOBAL GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 12:Â Â Â Â GLOBAL PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 13:Â Â Â Â GLOBAL PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 14:Â Â Â Â GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 15:Â Â Â Â GLOBAL MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16:Â Â Â Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 17:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY REGION, 2021-2028 (IN $ MILLION)
TABLE 18:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 19:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 20:Â Â Â Â NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 21:Â Â Â Â NORTH AMERICA APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 22:Â Â Â Â NORTH AMERICA GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 23:Â Â Â Â NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 24:Â Â Â Â NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 25:Â Â Â Â NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 26:Â Â Â Â NORTH AMERICA MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 27:Â Â Â Â NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 28:Â Â Â Â EUROPE PRECISION MEDICINE, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 29:Â Â Â Â EUROPE PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 30:Â Â Â Â EUROPE PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 31:Â Â Â Â EUROPE APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 32:Â Â Â Â EUROPE GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 33:Â Â Â Â EUROPE PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 34:Â Â Â Â EUROPE PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 35:Â Â Â Â EUROPE MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 36:Â Â Â Â EUROPE MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 37:Â Â Â Â EUROPE DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 38:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 39:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 40:Â Â Â Â ASIA-PACIFIC PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 41:Â Â Â Â ASIA-PACIFIC APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 42:Â Â Â Â ASIA-PACIFIC GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 43:Â Â Â Â ASIA-PACIFIC PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 44:Â Â Â Â ASIA-PACIFIC PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 45:Â Â Â Â ASIA-PACIFIC MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 46:Â Â Â Â ASIA-PACIFIC MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 47:Â Â Â Â ASIA-PACIFIC DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 48:Â Â Â Â LATIN AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 49:Â Â Â Â LATIN AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 50:Â Â Â Â LATIN AMERICA APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 51:Â Â Â Â LATIN AMERICA GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 52:Â Â Â Â LATIN AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 53:Â Â Â Â LATIN AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 54:Â Â Â Â LATIN AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 55:Â Â Â Â LATIN AMERICA MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 56:Â Â Â Â LATIN AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 57:Â Â Â Â REST OF LATIN AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 58:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 59:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 60:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION MEDICINE MARKET, BY COMPONENT, 2021-2028 (IN $ MILLION)
TABLE 61:Â Â Â Â MIDDLE EAST AND AFRICA APPLIED SCIENCE MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 62:Â Â Â Â MIDDLE EAST AND AFRICA GENOMICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 63:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION THERAPEUTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 64:Â Â Â Â MIDDLE EAST AND AFRICA PRECISION DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 65:Â Â Â Â MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 66:Â Â Â Â MIDDLE EAST AND AFRICA MEDICAL IMAGING MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 67:Â Â Â Â MIDDLE EAST AND AFRICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
FIGURE 1:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 2:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY APPLICATION, 2020 & 2028
FIGURE 3:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 4:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY INFECTIOUS DISEASES, 2021-2028 (IN $ MILLION)
FIGURE 5:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY NEUROLOGY/PHYSIATRY, 2021-2028 (IN $ MILLION)
FIGURE 6:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY CARDIOVASCULAR, 2021-2028 (IN $ MILLION)
FIGURE 7:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY LIFESTYLE AND ENDOCRINOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 8:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY GASTROENTEROLOGY, 2021-2028 (IN $ MILLION)
FIGURE 9:Â Â Â Â GLOBAL PRECISION MEDICINE MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 10:Â GLOBAL PRECISION MEDICINE MARKET, BY COMPONENT, 2020 & 2028
FIGURE 11:Â GLOBAL PRECISION MEDICINE MARKET, BY APPLIED SCIENCE, 2021-2028 (IN $ MILLION)
FIGURE 12:Â GLOBAL APPLIED SCIENCE MARKET, BY GENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 13:Â GLOBAL GENOMICS MARKET, BY PCR, 2021-2028 (IN $ MILLION)
FIGURE 14:Â GLOBAL GENOMICS MARKET, BY PM NGS, 2021-2028 (IN $ MILLION)
FIGURE 15:Â GLOBAL GENOMICS MARKET, BY GENOME EDITING, 2021-2028 (IN $ MILLION)
FIGURE 16:Â GLOBAL GENOMICS MARKET, OTHER GENOMICS TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 17:Â GLOBAL APPLIED SCIENCE MARKET, BY PHARMACOGENOMICS, 2021-2028 (IN $ MILLION)
FIGURE 18:Â BIOMARKERS ROLE IN PHARMACOGENOMICS
FIGURE 19:Â GLOBAL APPLIED SCIENCE MARKET, BY OTHER APPLIED SCIENCES, 2021-2028 (IN $ MILLION)
FIGURE 20:Â GLOBAL PRECISION MEDICINE MARKET, BY PRECISION THERAPEUTICS, 2021-2028 (IN $ MILLION)
FIGURE 21:Â GLOBAL PRECISION THERAPEUTICS MARKET, BY CLINICAL TRIALS, 2021-2028 (IN $ MILLION)
FIGURE 22:Â GLOBAL PRECISION THERAPEUTICS MARKET, BY CELL THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 23:Â GLOBAL PRECISION THERAPEUTICS MARKET, BY DRUG DISCOVERY AND RESEARCH, 2021-2028 (IN $ MILLION)
FIGURE 24:Â GLOBAL PRECISION THERAPEUTICS MARKET, BY GENE THERAPY, 2021-2028 (IN $ MILLION)
FIGURE 25:Â GLOBAL PRECISION MEDICINE MARKET, BY PRECISION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 26:Â GLOBAL PRECISION DIAGNOSTICS MARKET, BY MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 27:Â GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY NON-INVASIVE PRENATAL TESTING (NIPT), 2021-2028 (IN $ MILLION)
FIGURE 28:Â GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 29:Â GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY LIQUID BIOPSY, 2021-2028 (IN $ MILLION)
FIGURE 30:Â GLOBAL MOLECULAR DIAGNOSTICS MARKET, BY OTHER MOLECULAR DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 31:Â GLOBAL PRECISION DIAGNOSTICS MARKET, BY MEDICAL IMAGING, 2021-2028 (IN $ MILLION)
FIGURE 32:Â GLOBAL MEDICAL IMAGING MARKET, BY IMAGING ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 33:Â GLOBAL MEDICAL IMAGING MARKET, BY IMAGING COMPUTER-AIDED DETECTION (CADX), 2021-2028 (IN $ MILLION)
FIGURE 34:Â GLOBAL PRECISION MEDICINE MARKET, BY DIGITAL HEALTH AND INFORMATION TECHNOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 35:Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY CLINICAL DECISION SUPPORT SYSTEMS (CDSS), 2021-2028 (IN $ MILLION)
FIGURE 36:Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY BIG DATA ANALYTICS, 2021-2028 (IN $ MILLION)
FIGURE 37:Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IT INFRASTRUCTURE, 2021-2028 (IN $ MILLION)
FIGURE 38:Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY GENOMICS INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 39:Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY IN-SILICO INFORMATICS, 2021-2028 (IN $ MILLION)
FIGURE 40:Â GLOBAL DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY MOBILE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 41:Â GLOBAL PRECISION MEDICINE MARKET, BY REGION, 2020 & 2028
FIGURE 42:Â UNITED STATES PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 43:Â CANADA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 44:Â GERMANY PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 45:Â FRANCE PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 46:Â UNITED KINGDOM PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 47:Â ITALY PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 48:Â RUSSIA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 49:Â SPAIN PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 50:Â REST OF EUROPE PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 51:Â CHINA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 52:Â JAPAN PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 53:Â AUSTRALIA & NEW ZEALAND PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 54:Â INDIA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 55:Â SOUTH KOREA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 56:Â ASEAN COUNTRIES PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 57:Â REST OF ASIA-PACIFIC PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 58:Â LATIN AMERICA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 59:Â MEXICO PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 60:Â BRAZIL PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 61:Â REST OF LATIN AMERICA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 62:Â SAUDI ARABIA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 63:Â UNITED ARAB EMIRATES PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 64:Â TURKEY PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 65:Â SOUTH AFRICA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)
FIGURE 66:Â REST OF MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET 2021-2028 (IN $ MILLION)